Sunday, July 22, 2012 Saturday, July 21, 2012 Friday, July 20, 2012- Has This Obesity-Drug Maker Gained Too Much Weight?at Motley Fool (Fri, 20 Jul)
- Equity Briefing: Upgrades and Downgrades for July 19th: ABT, CYS, EQIX, EQR, FFIV, FRO, HUSA, INFA, JCI, LMCAACN Newswire (Fri, 20 Jul)
- Jim Cramer Watchdog: BUY Abbott Labs and These 3 HOT Stocks Nowat Wall St. Cheat Sheet (Fri, 20 Jul)
- S&P 500 Analyst Target Price Changes for July 20at Bloomberg (Fri, 20 Jul)
- S&P 500 Analyst Recommendation Changes for July 20at Bloomberg (Fri, 20 Jul)
- S&P 500 Analyst Estimate Revisions for July 20at Bloomberg (Fri, 20 Jul)
- The Market Has Already Discounted Merck's New Drugat Seeking Alpha (Fri, 20 Jul)
- Abbott Laboratories Earnings Call INSIGHTS: Unchanged Guidance, Nutritionalsat Wall St. Cheat Sheet (Fri, 20 Jul)
- While Not Expensive, Both Halves Of Abbott Need Workat Seeking Alpha (Fri, 20 Jul)
- Seeking Consistency And Predictabilityat Seeking Alpha (Fri, 20 Jul)
Thursday, July 19, 2012 | |
|